Fengrong Wang
Overview
Explore the profile of Fengrong Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thaprawat P, Wang F, Chalasani S, Schultz T, Di Cristina M, Carruthers V
mSphere
. 2025 Feb;
:e0082924.
PMID: 39982060
Importance: It is estimated that up to a third of the human population is chronically infected with ; however, little is known about how this parasite persists long term within...
2.
Zhou J, Wang F, Yang S, Zhang Y, Liu Y, Zhao T, et al.
Bone Marrow Transplant
. 2025 Feb;
PMID: 39939432
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and rare hematological malignancy with poor clinical outcomes. Stem cell transplantation helps to achieve long-term survival in adults. However, the benefit...
3.
Dou X, Liu R, Liu Y, Peng N, Wen L, Deng D, et al.
Ther Adv Hematol
. 2025 Feb;
16:20406207251314696.
PMID: 39897505
Background: Macrofocal multiple myeloma (MFMM) is characterized by clonal plasma cells comprising less than 20% of the bone marrow, multiple lytic bone lesions, and the absence of anemia, renal insufficiency,...
4.
Wang F, Zhao Q, Liu W, Zhang D, Dai X, Zhou W, et al.
Biochem Biophys Res Commun
. 2025 Jan;
749:151347.
PMID: 39847994
Agonistic monoclonal antibodies targeting 4-1BB have shown much preclinical promise, but their clinical development has been limited by obvious toxicity or unremarkable efficacy. Here, we generated two humanized anti-B7H3 × ...
5.
Li M, Li Y, Qu Q, Wang C, Chen Q, Zhu X, et al.
Cancer Lett
. 2025 Jan;
612:217460.
PMID: 39805391
Therapy-related acute myeloid leukemia (t-AML), which develops after cytotoxic therapy, has a poorer prognosis. Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potential cure, its efficacy varies among patients....
6.
Wang L, Chen Y, Zang M, Zhou J, Xiao M, Fu H, et al.
Cancer
. 2025 Jan;
131(2):e35717.
PMID: 39760486
Background: Patients with lysine methyltransferase 2a (KMT2A)-rearranged (KMT2A-r) acute myeloid leukemia (AML) are assigned to intermediate-risk and adverse-risk categories at diagnosis. However, the value of molecular measurable residual disease (MRD)...
7.
Dou X, Ren J, Li J, Liu X, Bao L, Chen Y, et al.
Cancer Med
. 2025 Jan;
14(1):e70573.
PMID: 39744915
Background: This study compares the efficacy and safety of single autologous stem cell transplantation (ASCT) versus tandem ASCT for multiple myeloma (MM) patients in the era of novel agents. Methods:...
8.
Rimple P, Olafsson E, Markus B, Wang F, Augusto L, Lourido S, et al.
bioRxiv
. 2024 Dec;
PMID: 39651188
Importance: is an obligate intracellular pathogen that infects virtually any nucleated cell in most warm-blooded animals. Infections are asymptomatic in most cases but people with weakened immunity can experience severe...
9.
Thaprawat P, Zhang Z, Rentchler E, Wang F, Chalasani S, Giuliano C, et al.
Autophagy Rep
. 2024 Nov;
3(1).
PMID: 39600488
is a ubiquitous protozoan parasite that can reside long-term within hosts as intracellular tissue cysts comprised of chronic stage bradyzoites. To perturb chronic infection requires a better understanding of the...
10.
Wang Y, Gao X, Wang T, Zhang X, Xu L, Wang Y, et al.
Chin J Cancer Res
. 2024 Nov;
36(5):530-544.
PMID: 39539811
Objective: We aimed to compare the quality-adjusted time without symptoms or toxicity (Q-TWiST) in acute myeloid leukemia (AML) patients who received haploidentical-related donor (HID) and identical sibling donor (ISD) hematopoietic...